Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the safety and efficacy of two different
immunosuppressive regimens (sequential tacrolimus/mycophenolate mofetil [MMF] plus steroids
versus tacrolimus plus MMF, following induction with daclizumab) in recipients of marginal
donor kidneys.